Abstract
Angiogenesis is critical to the growth and metastasis of solid tumors, and acquired drug resistance is one of the major hindrances to chemotherapy. Thus, we sought a rational strategy using the combination of antiangiogenic biotherapy and chemotherapy for cancer therapy. We explored the efficacy of a strategy combining low-dose cisplatin and a recombinant xenogeneic endoglin as a protein vaccine, which we previously demonstrated to have effective antiangiogenic effects in several mouse models. We found that both low-dosage cisplatin and xenogeneic endoglin vaccine individually resulted in effective suppression of tumor growth in 2 tumor models via inhibition of tumor angiogenesis. Remarkably, the combination therapy resulted in not only significant antiangiogenic effects but also additional promotion of tumor cell apoptosis and inhibition of tumor cell proliferation, without any ensuing increase in host toxicity during the course of treatment, which lasted for 6 months. In addition, the combination demonstrated a synergistic relationship, which was shown in all of the synergistic indexes, i.e., tumor volume, angiogenesis, apoptosis and proliferation. Both antibodies and antibody-producing B cells against mouse self-endoglin wer...Continue Reading
Citations
Oct 13, 2005·Cancer Immunology, Immunotherapy : CII·Valeska HofmeisterJürgen C Becker
Oct 18, 2008·Cancer Immunology, Immunotherapy : CII·Tianqian Zhang, Dorothee Herlyn
Nov 6, 2010·Cancer Gene Therapy·Y XieJ Yang
Mar 9, 2013·Cancer Gene Therapy·D LiJ Yang
Apr 13, 2012·Gene Therapy·M JaroszS Szala
Sep 27, 2007·Nature Reviews. Molecular Cell Biology·Peter ten Dijke, Helen M Arthur
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hua ZhongGalina V Shurin
Mar 10, 2011·Vascular Cell·Agata MatejukArchibald J Mixson
May 17, 2012·PloS One·Weiwei JiangZichun Hua
Jul 30, 2011·World Journal of Gastroenterology : WJG·Xiang HuangLong-Bang Chen
Feb 18, 2016·Molecular Neurobiology·Xiangyi KongRenzhi Wang
Apr 14, 2015·Seminars in Cancer Biology·Stephanie C CaseyDean W Felsher
Dec 1, 2009·Neurosurgery Clinics of North America·James L FrazierAlessandro Olivi
Oct 24, 2013·International Journal of Cancer. Journal International Du Cancer·Feng-Ying HuangGuang-Hong Tan
Aug 29, 2012·International Journal of Cancer. Journal International Du Cancer·Mariana S Nars, Ramon Kaneno
Aug 24, 2013·Parasite Immunology·J Joshi, S Kaur
Jun 12, 2010·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Gino MarioniAlberto Staffieri
Mar 8, 2006·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Y OkajiK Takahashi
Jan 20, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Feng-ying HuangYing-ying Lin
Jan 19, 2013·Expert Opinion on Therapeutic Targets·Madelon PaauweLukas J A C Hawinkels
Feb 3, 2015·Biochimica Et Biophysica Acta·Madelon Q WentinkArjan W Griffioen
Jan 10, 2012·Asian Pacific Journal of Tropical Medicine·Yue-Nan LiPeng Zhou
Feb 7, 2012·Asian Pacific Journal of Tropical Medicine·Feng-Ying HuangGuang-Hong Tan
Jul 18, 2009·Biochimica Et Biophysica Acta·Carmelo BernabeuMiguel Quintanilla
May 5, 2006·Gene Therapy·R ZhangY-Q Wei
Aug 11, 2007·Immunological Investigations·Guang-Hong TanJie Jang
May 13, 2008·Expert Review of Anticancer Therapy·Richard G EversonJohn H Sampson
Apr 26, 2013·Oncology Reports·Feng-Ying HuangYing-Ying Lin
Oct 11, 2011·Cancer Research·Tetsuya KodamaShiro Mori
Jan 16, 2021·ACS Biomaterials Science & Engineering·Jie WangHao Wang